Mihm Jr., MD, FASCP, FACP, is a well-versed dermatologist and dermatopatologist and an internationally renowned expert and consultant for pigmented lesions, lymphoma, and cutaneous inflammatory diseases. He currently serves as Director of the Mihm Cutaneous Pathology Consultative Service at Brigham and Women’s Hospital, Director of the Melanoma Program in the Department of Dermatology at Brigham and Women’s Hospital, Associate Director of the Center for Melanoma Oncology Dana Farber/Brigham and Women’s Cancer Center, Co-Director of The Melanoma Center and Pigmented Lesion Center (PLC) at Massachusetts General Hospital, and Professor at Harvard Medical School (1980-present) in Boston, Massachusetts. has an impressive professional journey that spans more than fifty years and his areas of expertise cover all facets of dermatology and dermatopathology. “The Mihm Cutaneous Pathology Consultative Service (MCPCS) is a second opinion dermatopathology service directed by Martin C. Mihm Jr., MD, who brings 30 years of expertise and is triple board certified in dermatology, pathology and dermatopathology. Dr. Mihm is a world renowned international consultant for melanoma and other skin tumors, including lymphoma”, states the official website of the Mihm Cutaneous Pathology Consultative Service (MCPCS). Dr. Mihm’s extensive knowledge and unmatched expertise in the fields of pigmented lesions, melanoma, non-melanoma skin cancers, and inflammatory disorders has made his opinion one that is highly sought after. “To date, he has consulted on more than 300,000 cases, nationally and worldwide. He continues to offer accurate diagnosis, prognosis, and treatment recommendations on routine and challenging cases in dermatology/dermatopathology”, states the same source. Mihm Jr., please visit https://www.brighamandwomens.org/dermatology/consultation-second-opinion-service/mihm-cutaneous-pathology-consultative-service-overview.
